JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yao, Z.
Right arrow Articles by Carrasquillo, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yao, Z.
Right arrow Articles by Carrasquillo, J. A.

Comparative Cellular Catabolism and Retention of Astatine-, Bismuth-, and Lead-Radiolabeled Internalizing Monoclonal Antibody

Zhengsheng Yao, Kayhan Garmestani, Karen J. Wong, Luke S. Park, Ekaterina Dadachova, Alexander Yordanov, Thomas A. Waldmann, William C. Eckelman, Chang H. Paik and Jorge A. Carrasquillo

Department of Nuclear Medicine and PET Department, Warren G. Magnuson Clinical Center; and Metabolism and Radiation Oncology Branches, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland



View larger version (26K):

[in a new window]
 
FIGURE 1. Retention and release of 125I-, 211At-, 111In-, 205,6Bi-, and 203Pb-labeled T101 by PBMNC were determined. PBMNC (106) were incubated with 100 ng trace-labeled T101 at 4°C for 1 h and then washed, placed in fresh culture medium, and incubated at 37°C for 0, 1, 2, 4, and 8 h before quantifying amounts of cell-associated radioactivity and amount released into supernatant. Supernatant radioactivity was fractionated into methanol-precipitable noncatabolized component and methanol-soluble catabolized fraction. SD bars are plotted for replicates but are too small to be visualized for most time points.

 


View larger version (24K):

[in a new window]
 
FIGURE 2. Retention and release of various {gamma}- and {alpha}-emitter–labeled T101s by MOLT-4 cell line were determined as described for Figure 1.

 


View larger version (24K):

[in a new window]
 
FIGURE 3. Percentage (mean ± SD) of acid-resistant to total cell-bound radioactivity for radiolabeled T101 by PBMNC. Labeled T101 was allowed to bind to PBMNC at 4°C for 1 h to obtain surface labeling with minimal internalization. Aliquots of 106 cells were then placed into separate tubes and supernatants were separated from cells. Immediately after separation, cells underwent acid wash and acid-resistant radioactivity was determined by counting cell pellets after centrifugation. This procedure was repeated at various times after transferring cell aliquots to incubator at 37°C. Acid-resistant fraction was determined by dividing activity in cell pellet after acid wash by total activity on cell after 1 h of incubation at 4°C.

 


View larger version (30K):

[in a new window]
 
FIGURE 4. Intracellular distribution of 125I-, 211At-, 111In-, 205,6Bi-, and 203Pb-labeled T101 in PBMNC. PBMNC incubated with radiolabeled T101 were suspended in TES buffer and disrupted. Cell nuclei and unbroken cells were removed by centrifugation at 250g. Supernatants were applied to Percoll/TES buffer and ultracentrifuged at 4°C for 60 min at 20,000g. Serial 0.5 mL fractions were collected from top and counted for radioactivity. Early fractions represent activity on cell surface and late fractions represent activity in lysosomes (fraction 14). Location of lysosome fraction was confirmed using enzyme marker ß-galactosidase (data not shown).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.